- Home
- / Shanghai Rightongene Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Shanghai Rightongene Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥17.8
2024-10-29
Market Capitalization
¥947.9 M
2024-10-29
Revenue
¥170.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 209.4M | 241.1M | 264.4M | 269.8M | 414.9M | 243.8M | 232.7M | 170.7M |
| Cost of goods sold | 52.9M | 49.6M | 80.2M | 78.2M | 166.3M | 69.2M | 61.7M | 43.6M |
| Gross profit | 170.8M | 205.2M | 204.0M | 211.9M | 256.8M | 186.8M | 178.3M | 130.3M |
| Gross profit margin, % | 81.6% | 85.1% | 77.2% | 78.5% | 61.9% | 76.6% | 76.6% | 76.3% |
| Operating expense total | 118.6M | 147.6M | 135.7M | 150.9M | 143.3M | 151.5M | 149.9M | 113.9M |
| Depreciation and amortization | 40.0M | 20.4M | 28.4M | 33.0M | 44.8M | 46.7M | 56.5M | 62.1M |
| EBITDA | 52.2M | 57.6M | 68.3M | 61.0M | 113.5M | 35.4M | 28.4M | 16.4M |
| EBITDA margin, % | 24.9% | 23.9% | 25.8% | 22.6% | 27.4% | 14.5% | 12.2% | 9.6% |
| EBIT | 6.8M | 32.5M | 43.3M | 40.5M | 62.7M | (15.8M) | (32.9M) | (54.1M) |
| EBIT margin, % | 3.2% | 13.5% | 16.4% | 15.0% | 15.1% | -6.5% | -14.2% | -31.7% |
| Interest income | 2.4M | 2.5M | 1.4M | 2.6M | 2.2M | 3.8M | 3.2M | 2.3M |
| Interest expense | 13.0K | 181.0K | 61.0K | 492.0K | 550.0K | 828.0K | 885.0K | 193.0K |
| Pre tax profit | 16.9M | 37.1M | 40.1M | 42.4M | 71.5M | (9.4M) | (28.5M) | (50.7M) |
| Income tax expense | 2.3M | 1.1M | 1.3M | 2.4M | 5.6M | (4.6M) | (2.6M) | 9.7M |
| Net Income | 14.6M | 35.9M | 38.8M | 40.1M | 65.9M | (4.8M) | (25.9M) | (60.4M) |